26
Participants
Start Date
June 5, 2018
Primary Completion Date
September 30, 2021
Study Completion Date
February 11, 2022
3BNC117
Intravenous infusion of 3BNC117
10-1074
Intravenous infusion of 3BNC117
Analytical treatment interruption
Analytical treatment interruption
The Rockefeller University, New York
Ragon Institute of MGH, MIT, and Harvard, Boston
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Ragon Institute of MGH, MIT and Harvard
OTHER
Montefiore Medical Center
OTHER
Rockefeller University
OTHER